These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


61 related items for PubMed ID: 5577966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Activator and inhibitor of fibrinolysis in the genital organs of the rat in the course of pregnancy].
    Januszko T, Buluk K.
    Acta Physiol Pol; 1966; 17(4):569-80. PubMed ID: 6007876
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K, Bruzgo I, Roszkowska-Jakimiec W, Worowski K.
    Acta Pol Pharm; 1994 Mar; 51(6):499-504. PubMed ID: 7762400
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antifibrinolytic action of the anticoagulant split product of fibrinogen.
    Nanninga LB, Guest MM.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):526-32. PubMed ID: 5708130
    [No Abstract] [Full Text] [Related]

  • 14. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG, Kirklin JK, George JF.
    Blood Coagul Fibrinolysis; 2009 Sep 31; 20(6):448-55. PubMed ID: 19581800
    [Abstract] [Full Text] [Related]

  • 15. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F, Klöcking HP.
    Biomed Biochim Acta; 1983 Sep 31; 42(6):725-30. PubMed ID: 6605748
    [Abstract] [Full Text] [Related]

  • 16. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N.
    Pol J Pharmacol; 1996 Sep 31; 48(2):215-20. PubMed ID: 9112654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The inactivation of single-chain urokinase-type plasminogen activator by thrombin may provide an additional explanation for the antifibrinolytic effect of factor XI.
    Braat EA, Rijken DC.
    Thromb Haemost; 1999 Apr 31; 81(4):657. PubMed ID: 10235456
    [No Abstract] [Full Text] [Related]

  • 19. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000 Apr 31; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.